Y
Yapan Bio
Biotech & Life Sciences · Hyderabad, India · Founded 2019
Your Collaborative Partner in Process Development and GMP Manufacturing for Vaccines and Biologics/Bio-therapeutics MoreLess
Yapan Bio is a specialized company operating in the biotechnology sector, focusing on the development and manufacturing of vaccines and biologics, which are medical products derived from living organisms. The company is strategically located in Genome Valley, Hyderabad, India, a premier hub for research and development (R&D) and clean manufacturing.
Yapan Bio serves a diverse range of clients, including pharmaceutical companies, biotech firms, and research institutions. These clients are typically involved in the early-stage research and development of new vaccines and biologics, and they rely on Yapan Bio for its expertise in process development and Good Manufacturing Practice (GMP) manufacturing. GMP refers to regulations that ensure products are consistently produced and controlled according to quality standards.
The company operates in the highly specialized market of biopharmaceutical manufacturing, which requires stringent quality control and regulatory compliance. Yapan Bio offers integrated services that span from early-stage research and process development to scale-up and full-scale GMP manufacturing. This means they help clients optimize their production processes to achieve high product yields, stability, and consistent manufacturing output.
Yapan Bio's business model is service-based. They generate revenue by providing specialized services in process development, optimization, and GMP manufacturing. This includes upstream and downstream development, which refers to the different stages of biopharmaceutical production. Upstream development involves the initial stages of production, such as cell culture, while downstream development involves the purification and formulation of the final product.
In summary, Yapan Bio is a key player in the biopharmaceutical manufacturing industry, offering comprehensive services that help clients bring their vaccines and biologics from the research phase to clinical trials. Their state-of-the-art facilities and expertise make them a valuable partner in this highly regulated and specialized market.
Keywords: Biopharmaceutical, GMP manufacturing, vaccines, biologics, process development, scale-up, cell culture, purification, clinical trials, Genome Valley.
Company overview
Yapan Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2019
- Headquarters
- Hyderabad, India
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 80.4
Valuation & funding
Yapan Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Aug 2026 | $7.9M | $11M | Piramal Pharma | ↗ |
| EARLY VC✓Equity / VC | Dec 2021 | $14M | $55M | Piramal Healthcare | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 54 |
| 2025 | 48 |
| 2024 | 40 |
| 2023 | 31 |
| 2022 | 26 |
Growth signals
Yapan Bio website traffic
Latest recorded traffic for Yapan Bio is 6K monthly website visits, up 328.6% over the last three months. Yapan Bio's team grew 12.5% over the past year.
Comparisons
Yapan Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Yapan Bio's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Yapan Bio's cap table
Sourced from Dealroom's funding and investor records.


Global footprint
Where Yapan Bio has talent and traffic
team presence
In the news
Latest news about Yapan Bio
Recent press, funding announcements, and product moves mentioning Yapan Bio — open to read from the original sources.
Market sentiment
What the market is saying about Yapan Bio
An AI-synthesized read of the highest-engagement posts about Yapan Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yapan Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





